Respiri Ltd

AU:RSH Australia Medical Devices
Market Cap
$34.14 Million
AU$55.13 Million AUD
Market Cap Rank
#25001 Global
#532 in Australia
Share Price
AU$0.04
Change (1 day)
+0.00%
52-Week Range
AU$0.03 - AU$0.05
All Time High
AU$0.24
About

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limi… Read more

Respiri Ltd (RSH) - Net Assets

Latest net assets as of December 2024: AU$4.82 Million AUD

Based on the latest financial reports, Respiri Ltd (RSH) has net assets worth AU$4.82 Million AUD as of December 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$7.08 Million) and total liabilities (AU$2.26 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$4.82 Million
% of Total Assets 68.04%
Annual Growth Rate -6.94%
5-Year Change 5.7%
10-Year Change -32.39%
Growth Volatility 170.31

Respiri Ltd - Net Assets Trend (1999–2024)

This chart illustrates how Respiri Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Respiri Ltd (1999–2024)

The table below shows the annual net assets of Respiri Ltd from 1999 to 2024.

Year Net Assets Change
2024-06-30 AU$2.64 Million +218.90%
2023-06-30 AU$826.89K -72.51%
2022-06-30 AU$3.01 Million -60.27%
2021-06-30 AU$7.57 Million +203.44%
2020-06-30 AU$2.49 Million +259.64%
2019-06-30 AU$-1.56 Million -194.66%
2018-06-30 AU$1.65 Million -8.16%
2017-06-30 AU$1.80 Million -55.46%
2016-06-30 AU$4.04 Million +3.48%
2015-06-30 AU$3.90 Million -57.03%
2014-06-30 AU$9.08 Million +459.44%
2013-06-30 AU$1.62 Million -23.27%
2012-06-30 AU$2.11 Million +0.22%
2011-06-30 AU$2.11 Million -26.40%
2010-06-30 AU$2.87 Million -27.04%
2009-06-30 AU$3.93 Million -19.03%
2008-06-30 AU$4.85 Million +101.72%
2007-06-30 AU$2.41 Million +519.42%
2006-06-30 AU$388.37K -74.30%
2005-06-30 AU$1.51 Million +32.30%
2004-06-30 AU$1.14 Million +220.25%
2003-06-30 AU$-949.92K -168.85%
2002-06-30 AU$1.38 Million -89.61%
2001-06-30 AU$13.28 Million +74.83%
2000-06-30 AU$7.60 Million -52.35%
1999-06-30 AU$15.94 Million --

Equity Component Analysis

This analysis shows how different components contribute to Respiri Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 13846520400.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2024)

Component Amount Percentage
Common Stock AU$140.55 Million 5329.86%
Other Comprehensive Income AU$3.70 Million 140.42%
Total Equity AU$2.64 Million 100.00%

Respiri Ltd Competitors by Market Cap

The table below lists competitors of Respiri Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Respiri Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 826,890 to 2,636,940, a change of 1,810,050 (218.9%).
  • Net loss of 7,129,247 reduced equity.
  • Share repurchases of 559,852 reduced equity.
  • New share issuances of 8,808,757 increased equity.
  • Other comprehensive income decreased equity by 3,077,102.
  • Other factors increased equity by 3,767,494.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income AU$-7.13 Million -270.36%
Share Repurchases AU$559.85K -21.23%
Share Issuances AU$8.81 Million +334.05%
Other Comprehensive Income AU$-3.08 Million -116.69%
Other Changes AU$3.77 Million +142.87%
Total Change AU$- 218.90%

Book Value vs Market Value Analysis

This analysis compares Respiri Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 13.51x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 0.00x to 13.51x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1999-06-30 AU$254.52 AU$0.04 x
2000-06-30 AU$157.60 AU$0.04 x
2001-06-30 AU$135.81 AU$0.04 x
2002-06-30 AU$19.14 AU$0.04 x
2003-06-30 AU$-12.87 AU$0.04 x
2004-06-30 AU$1.10 AU$0.04 x
2005-06-30 AU$0.98 AU$0.04 x
2006-06-30 AU$0.15 AU$0.04 x
2007-06-30 AU$0.25 AU$0.04 x
2008-06-30 AU$0.25 AU$0.04 x
2009-06-30 AU$0.15 AU$0.04 x
2010-06-30 AU$0.08 AU$0.04 x
2011-06-30 AU$0.05 AU$0.04 x
2012-06-30 AU$0.02 AU$0.04 x
2013-06-30 AU$0.01 AU$0.04 x
2014-06-30 AU$0.03 AU$0.04 x
2015-06-30 AU$0.01 AU$0.04 x
2016-06-30 AU$0.01 AU$0.04 x
2017-06-30 AU$0.00 AU$0.04 x
2018-06-30 AU$0.00 AU$0.04 x
2019-06-30 AU$0.00 AU$0.04 x
2020-06-30 AU$0.00 AU$0.04 x
2021-06-30 AU$0.01 AU$0.04 x
2022-06-30 AU$0.00 AU$0.04 x
2023-06-30 AU$0.00 AU$0.04 x
2024-06-30 AU$0.00 AU$0.04 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Respiri Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -270.36%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -1560.30%
  • • Asset Turnover: 0.07x
  • • Equity Multiplier: 2.35x
  • Recent ROE (-270.36%) is below the historical average (-209.82%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1999 -5.72% 0.00% 0.00x 1.07x AU$-2.51 Million
2000 -80.23% -471.75% 0.13x 1.36x AU$-6.85 Million
2001 -65.47% -17744.90% 0.00x 1.12x AU$-10.02 Million
2002 -859.73% -23375.30% 0.02x 1.84x AU$-12.00 Million
2003 0.00% -148036.76% 0.01x 0.00x AU$-4.20 Million
2004 -19.74% -37.08% 0.47x 1.14x AU$-339.67K
2005 -47.92% -1395.06% 0.03x 1.05x AU$-875.31K
2006 -306.75% -3548.71% 0.08x 1.09x AU$-1.23 Million
2007 -213.02% -3435.56% 0.05x 1.27x AU$-5.36 Million
2008 -240.65% -11655.79% 0.02x 1.19x AU$-12.16 Million
2009 -170.54% -2972.56% 0.04x 1.30x AU$-7.09 Million
2010 -207.20% -1704.41% 0.08x 1.60x AU$-6.23 Million
2011 -316.49% -2010.71% 0.10x 1.59x AU$-6.89 Million
2012 -264.14% -43068.88% 0.00x 1.47x AU$-5.80 Million
2013 -344.16% -51419.55% 0.00x 1.75x AU$-5.75 Million
2014 -113.59% -54334.42% 0.00x 1.17x AU$-11.22 Million
2015 -140.10% -5813.98% 0.02x 1.33x AU$-5.85 Million
2016 -99.38% -591.80% 0.13x 1.26x AU$-4.41 Million
2017 -140.30% -305.48% 0.31x 1.47x AU$-2.70 Million
2018 -194.28% -372.30% 0.32x 1.61x AU$-3.37 Million
2019 0.00% -825.78% 1.01x 0.00x AU$-8.32 Million
2020 -291.05% -336.89% 0.47x 1.85x AU$-7.51 Million
2021 -145.84% -4087.90% 0.03x 1.20x AU$-11.80 Million
2022 -220.24% -2611.20% 0.06x 1.40x AU$-6.93 Million
2023 -698.44% -8188.07% 0.02x 3.85x AU$-5.86 Million
2024 -270.36% -1560.30% 0.07x 2.35x AU$-7.39 Million

Industry Comparison

This section compares Respiri Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $14,750,885
  • Average return on equity (ROE) among peers: -315.19%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Respiri Ltd (RSH) AU$4.82 Million -5.72% 0.47x $22.22 Million
4DMEDICAL Ltd (4DX) $926.64K -85.93% 0.18x $1.03 Billion
Adherium Ltd (ADR) $34.53 Million -3.63% 0.08x $2.37 Million
Aroa Biosurgery Ltd (ARX) $-22.65 Million 0.00% 0.00x $92.74 Million
Atomo Diagnostics Ltd (AT1) $34.48 Million -26.73% 0.05x $8.96 Million
Control Bionics Ltd (CBL) $6.09 Million -15.97% 0.04x $4.98 Million
Cardiex Ltd (CDX) $3.03 Million -101.61% 0.73x $4.25 Million
Compumedics Ltd (CMP) $9.21 Million -30.70% 1.16x $13.08 Million
Cochlear Ltd (COH) $75.42 Million 53.19% 1.13x $7.01 Billion
Cleo Diagnostics Ltd (COV) $5.83 Million -68.54% 0.19x $23.47 Million
Conneqt Health Limited (CQT) $633.50K -2871.98% 13.72x $4.66 Million